logo
Site Network

Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Medizinische Universität Innsbruck

+4351290030
epicenter@i-med.ac.at
Source: Site record.
http://www.i-med.ac.at

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

The Medical University of Innsbruck (Medizinische Universität Innsbruck), located in Tyrol, Austria, is the premier medical research and education institution in western Austria. While it has deep historical roots dating back to a Jesuit grammar school in 1562 and the founding of the university's Faculty of Medicine in 1674, it was established as a fully independent public university in 2004 after separating from the Leopold-Franzens University of Innsbruck.

Business Status

Source: Google. OPEN

Business Category

Source: Google. University

Business Subcategory

Source: Google. University
Source: Trial-derived.
28Total Trials
Source: Trial-derived.
5Recruiting Trials
Source: Trial-derived.
12Active Trials
Source: Trial-derived.
12Completed Trials
Source: Trial-derived.
41Unique Conditions
Source: Trial-derived.
33Unique Sponsors

Conditions

Source: Trial-derived. Acute Myeloid Leukemia (3)Source: Trial-derived. Chronic Migraine (2)Source: Trial-derived. Episodic Migraine (2)Source: Trial-derived. Ischaemic Stroke (2)Source: Trial-derived. Ischemic Stroke (2)Source: Trial-derived. Myelodysplastic Syndrome With Excess Blasts-2 (2)Source: Trial-derived. Parkinson Disease (2)Source: Trial-derived. Triple Negative Breast Cancer (2)

Sponsors

Source: Trial-derived. Medical University Innsbruck (8)Source: Trial-derived. VASCage GmbH (5)Source: Trial-derived. AbbVie (3)Source: Trial-derived. Deutsch-Österreichische Studiengruppe Akute Myeloische Leukämie (AMLSG) (2)Source: Trial-derived. Gilead Sciences (2)Source: Trial-derived. Merz Therapeutics GmbH (2)Source: Trial-derived. Novo Nordisk A/S (2)Source: Trial-derived. Stichting Hemato-Oncologie voor Volwassenen Nederland (2)

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Telehealth study visits

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. 12-lead ECG

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Specimen packaging and shipment
Source: AI-inferred. Timed pharmacokinetic sampling and processing

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration
Source: AI-inferred. Radiation therapy

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Neuropsychological assessment battery administration